Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F9N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,917
Award facts
- Contract value 100% obligated
- $22,916.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,916.96 to Amerisourcebergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials, with an ultimate completion date of January 28, 2026. The award was made on a firm fixed-price basis with no set-aside designation, indicating full and open competition. The product will be supplied from Amerisourcebergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate office as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic drugs, specialty medications, and related medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and other government healthcare systems. Cencora, Inc., which does business as Amerisourcebergen, is a prominent pharmaceutical distributor that has consistently demonstrated capability in fulfilling federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5F9N?
SPE2DR26F5F9N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F5F9N worth?
The government has obligated $22,917 on SPE2DR26F5F9N.
Is contract SPE2DR26F5F9N an order under another contract?
Yes. SPE2DR26F5F9N is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F9N competed?
The extent of competition for SPE2DR26F5F9N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award